Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-22-088832
Filing Date
2022-03-30
Accepted
2022-03-30 09:01:22
Documents
50
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d205626d10k.htm   iXBRL 10-K 1670559
2 EX-10.13 d205626dex1013.htm EX-10.13 9613
3 EX-23.1 d205626dex231.htm EX-23.1 1455
4 EX-31.1 d205626dex311.htm EX-31.1 10208
5 EX-31.2 d205626dex312.htm EX-31.2 10113
6 EX-32.1 d205626dex321.htm EX-32.1 3419
7 EX-32.2 d205626dex322.htm EX-32.2 3259
13 GRAPHIC g205626g82f30.jpg GRAPHIC 9575
  Complete submission text file 0001193125-22-088832.txt   4818416

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA inti-20211231.xsd EX-101.SCH 31728
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inti-20211231_cal.xml EX-101.CAL 25017
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inti-20211231_def.xml EX-101.DEF 162773
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE inti-20211231_lab.xml EX-101.LAB 285122
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inti-20211231_pre.xml EX-101.PRE 227734
44 EXTRACTED XBRL INSTANCE DOCUMENT d205626d10k_htm.xml XML 488481
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Filer) CIK: 0001042418 (see all company filings)

EIN.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13467 | Film No.: 22783437
SIC: 8731 Services-Commercial Physical & Biological Research